Endra Life Sciences Inc (NDRA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Operating Expenses | 1,622 | 1,371 | 1,301 | 1,469 | 4,297 |
| Operating Income | -1,622 | -1,371 | -1,301 | -1,469 | -4,297 |
| Other Income | -1,547 | -225 | 75 | 433 | 148 |
| Pre-tax Income | -3,169 | -1,596 | -1,226 | -1,036 | -4,149 |
| Net Income Continuous | -3,169 | -1,596 | -1,226 | -1,036 | -4,149 |
| Net Income | $-3,169 | $-1,596 | $-1,226 | $-1,036 | $-4,149 |
| EPS Basic Total Ops | -3.26 | -2.10 | -1.71 | -1.86 | 402.26 |
| EPS Basic Continuous Ops | -3.27 | -2.10 | -1.71 | -1.86 | 554.50 |
| EPS Diluted Total Ops | -3.26 | -2.10 | -1.71 | -1.86 | 402.26 |
| EPS Diluted Continuous Ops | -3.27 | -2.10 | -1.71 | -1.86 | 554.50 |
| EPS Diluted Before Non-Recurring Items | -1.67 | -1.75 | -1.71 | -2.59 | -9.40 |
| EBITDA(a) | $-1,583 | $-1,331 | $-1,268 | $-1,424 | $-4,250 |